The Genotype-Tissue Expression (GTEx) project
John T. Lonsdale, Deborah Bradbury(Science Applications International Corporation (United States)), Dan Maxim(Van Andel Institute), Greg E. Korzeniewski(Science Applications International Corporation (United States)), Charles Shive(Science Applications International Corporation (United States)), Johnelle Fleming(Phoenix (United States)), Dana Filkins(Van Andel Institute), Laura K. Barker(Virginia Commonwealth University), Kristin Feenstra(Van Andel Institute), Phillip Branton, Robin Burges(Science Applications International Corporation (United States)), Angela Zimmerman(Science Applications International Corporation (United States)), Harold I. Magazine(Phoenix (United States)), Bree D. Berghuis(Van Andel Institute), David E. Tabor(AstraZeneca (United States)), Mike Salvatore, Scott D. Jewell(Van Andel Institute), Eddie Cortadillo(Van Andel Institute), Mike Moser(Roswell Park Comprehensive Cancer Center), Gary Walters(Lifenet Health), Jeffrey A. Thomas, Kevin Groch(Science Applications International Corporation (United States)), Sreenath Nampally(Science Applications International Corporation (United States)), Kimberley D. Ramsey(Roswell Park Comprehensive Cancer Center), Maghboeba Mosavel(Virginia Commonwealth University), Edmund Lo, Jason Bridge, Richard Hasz(Gift of Life Michigan), Dan Rohrer(Van Andel Institute), Ellen Karasik, P.R. Harbach(Van Andel Institute), Saboor Shad, Laura A. Siminoff(Case Western Reserve University), Liqun Qi(Science Applications International Corporation (United States)), Steve Buia(Science Applications International Corporation (United States)), Heather M. Traino(Virginia Commonwealth University), Bryan M. Gillard(Roswell Park Comprehensive Cancer Center), Kim Valentino(Science Applications International Corporation (United States)), Eric A. Hudson(Freie Universität Berlin), Lisa Turner(Van Andel Institute), Karna Robinson(Science Applications International Corporation (United States)), Anna M. Smith(Science Applications International Corporation (United States)), J Robb(Science Applications International Corporation (United States)), Rebecca Phillips, Susan Sullivan, Fernando U. Garcia(Drexel University), Leslie H. Sobin(Leidos (United States)), John Syron(Phoenix (United States)), Nancy Young(Augusta University), Barbara A. Foster(Roswell Park Comprehensive Cancer Center)
Cited by 266
Related Papers
Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1β), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe<i>Plasmodium falciparum</i>Malaria and Matched Uncomplicated Malaria or Healthy Controls
|Infection and Immunity|2004|447
Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade.
|PubMed|2000|427
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
|Proceedings of the National Academy of Sciences|1997|393
Omalizumab treatment downregulates dendritic cell FcεRI expression
|Journal of Allergy and Clinical Immunology|2003|346